ArticleCureus2026
Breast Gangrene Associated With Thrombotic Vasculopathy: A Case Report.
Article in Cureus, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
This article aimed to report a patient with breast gangrene secondary to occlusive thrombotic vasculopathy. A 50-year-old woman with a history of long-standing rheumatoid arthritis presented with a rapidly progressing necrotic ulcer on her right breast. Tests showed active rheumatoid arthritis. Biopsy revealed epidermal necrosis and thrombotic vasculopathy with fibrinous thrombi. The patient was diagnosed with breast gangrene secondary to thrombotic vasculopathy associated with rheumatoid arthritis. Prednisone and methotrexate were initiated with a favorable response, but the patient was subsequently lost to follow-up. Breast gangrene is a rare and potentially life-threatening condition, most commonly associated with necrotizing fasciitis and favored by severe infections, microangiopathy, multiple comorbidities, trauma, iatrogenic procedures, immunosuppression, and idiopathic forms. Management relies on prompt surgical debridement and broad-spectrum antibiotic therapy; in extensive cases, reconstructive surgery or mastectomy may be required due to the condition's high morbidity and mortality. Although it has been linked to other autoimmune diseases, an association with thrombotic vasculopathy has not been previously reported.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.